Global Blood Glucose Monitoring Systems Market Size study, by Device (Continuous Blood Glucose Monitoring Systems, Self-Monitoring Blood Glucose Monitoring Systems), by Type (Invasive, Non-Invasive), by Modality (Wearable, Non-Wearable), by Distribution Channel (Institutional Sales, Retail Sales) and Regional Forecasts 2020-2026

  • Product Code:
    RP-ID-10321980
  • Published Date:
    May 2020 (Upgradation in process)
  • Region:
    Global
  • Pages:
    200
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Global Blood Glucose Monitoring Systems Market is valued approximately at USD 10.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6.8% over the forecast period 2020-2026. A Blood glucose monitoring system is a type of diagnostics system that is used for the care and treatment of diabetes. It is used to measure and monitor the levels of blood sugar in the patients. These systems also help in preventing other health-related conditions such as neuropathy, retinopathy, and cardiovascular diseases. There are several types of blood glucose monitoring systems available in the market varying in price, size, duration of testing time, and ease of utilization. Rising prevalence of diseases such as diabetes and cardiovascular diseases, high availability of reimbursements, with the growing awareness programs about diabetes preventive care are the few factors responsible for high CAGR of the market over the forecast period. According to the International Agency for Research on Cancer (IARC), in 2018, there were around 17.0 million new cancer cases and 9.5 million cancer deaths registered throughout the world. Also, the global burden of cancer is expected to grow to almost 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. Similarly, according to the American Heart Association, the occurrence of death due to cardiovascular diseases was about 17.6 million in 2016, and a number is expected to grow to over 23.6 million by 2030. This, in turn, is anticipated to accelerate the demand for Blood Glucose Monitoring Systems around the world. However, high cost and poor reimbursement are the few factors expected to limit the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Blood Glucose Monitoring Systems market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the favorable reimbursements policies, rising awareness programs for diabetes owing to its high prevalence, and rising FDA approvals in for these systems and supplies in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to large number of diabetic patients and rapid economic growth in countries such as China and India.

Major market player included in this report are:
F. Hoffman-La Roche Ltd.
Abbott Laboratories
Ascencia Diabetes Care Holdings AG
Dexcom Inc.
Medtronic
B. Braun Melsungen AG
Lifescan Inc.
Terumo Medical Corporation
DiamonTech GmbH
Nova Biomedical

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Device:
Continuous Blood Glucose Monitoring Systems
Self-Monitoring Blood Glucose Monitoring Systems

By Type:
Invasive
Non-Invasive

By Modality:
Wearable
Non-Wearable

By Distribution Channel:
Institutional sales
Retail Sales

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Blood Glucose Monitoring Systems Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Blood Glucose Monitoring Systems Market, by Region, 2018-2026 (USD Billion)
1.2.2. Blood Glucose Monitoring Systems Market, by Device, 2018-2026 (USD Billion)
1.2.3. Blood Glucose Monitoring Systems Market, by Type, 2018-2026 (USD Billion)
1.2.4. Blood Glucose Monitoring Systems Market, by Modality, 2018-2026 (USD Billion)
1.2.5. Blood Glucose Monitoring Systems Market, by Distribution Channel, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Blood Glucose Monitoring Systems Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Blood Glucose Monitoring Systems Market Dynamics
3.1. Blood Glucose Monitoring Systems Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Blood Glucose Monitoring Systems Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Blood Glucose Monitoring Systems Market, by Device
5.1. Market Snapshot
5.2. Global Blood Glucose Monitoring Systems Market by Device, Performance - Potential Analysis
5.3. Global Blood Glucose Monitoring Systems Market Estimates & Forecasts by Device 2016-2026 (USD Billion)
5.4. Blood Glucose Monitoring Systems Market, Sub Segment Analysis
5.4.1. Continuous Blood Glucose Monitoring Systems
5.4.2. Self-Monitoring Blood Glucose Monitoring Systems
Chapter 6. Global Blood Glucose Monitoring Systems Market, by Type
6.1. Market Snapshot
6.2. Global Blood Glucose Monitoring Systems Market by Type, Performance - Potential Analysis
6.3. Global Blood Glucose Monitoring Systems Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
6.4. Blood Glucose Monitoring Systems Market, Sub Segment Analysis
6.4.1. Invasive
6.4.2. Non-Invasive
Chapter 7. Global Blood Glucose Monitoring Systems Market, by Modality
7.1. Market Snapshot
7.2. Global Blood Glucose Monitoring Systems Market by Modality, Performance - Potential Analysis
7.3. Global Blood Glucose Monitoring Systems Market Estimates & Forecasts by Modality 2016-2026 (USD Billion)
7.4. Blood Glucose Monitoring Systems Market, Sub Segment Analysis
7.4.1. Wearable
7.4.2. Non-Wearable
Chapter 8. Global Blood Glucose Monitoring Systems Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Blood Glucose Monitoring Systems Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Blood Glucose Monitoring Systems Market Estimates & Forecasts by Distribution Channel 2016-2026 (USD Billion)
8.4. Blood Glucose Monitoring Systems Market, Sub Segment Analysis
8.4.1. Institutional sales
8.4.2. Retail Sales
Chapter 9. Global Blood Glucose Monitoring Systems Market, Regional Analysis
9.1. Blood Glucose Monitoring Systems Market, Regional Market Snapshot
9.2. North America Blood Glucose Monitoring Systems Market
9.2.1. U.S. Blood Glucose Monitoring Systems Market
9.2.1.1. Device breakdown estimates & forecasts, 2016-2026
9.2.1.2. Type breakdown estimates & forecasts, 2016-2026
9.2.1.3. Modality breakdown estimates & forecasts, 2016-2026
9.2.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Blood Glucose Monitoring Systems Market
9.3. Europe Blood Glucose Monitoring Systems Market Snapshot
9.3.1. U.K. Blood Glucose Monitoring Systems Market
9.3.2. Germany Blood Glucose Monitoring Systems Market
9.3.3. Rest of Europe Blood Glucose Monitoring Systems Market
9.4. Asia-Pacific Blood Glucose Monitoring Systems Market Snapshot
9.4.1. China Blood Glucose Monitoring Systems Market
9.4.2. India Blood Glucose Monitoring Systems Market
9.4.3. Japan Blood Glucose Monitoring Systems Market
9.4.4. Rest of Asia Pacific Blood Glucose Monitoring Systems Market
9.5. Latin America Blood Glucose Monitoring Systems Market Snapshot
9.5.1. Brazil Blood Glucose Monitoring Systems Market
9.5.2. Mexico Blood Glucose Monitoring Systems Market
9.6. Rest of The World Blood Glucose Monitoring Systems Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. F. Hoffman-La Roche Ltd.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. Ascencia Diabetes Care Holdings AG
10.2.4. Dexcom, Inc.
10.2.5. Medtronic
10.2.6. B. Braun Melsungen AG
10.2.7. Lifescan Inc.
10.2.8. Terumo Medical Corporation
10.2.9. DiamonTech GmbH
10.2.10. Nova Biomedical
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research AssumptionList of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY DEVICE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY MODALITY 2016-2026 (USD BILLION)
TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2016-2026 (USD BILLION)
TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. U.S. BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. U.S. BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 23. U.S. BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. CANADA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 26. CANADA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28. UK BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29. UK BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 31. GERMANY BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. GERMANY BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 34. ROE BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. ROE BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 37. CHINA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. CHINA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 40. INDIA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. INDIA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 43. JAPAN BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. JAPAN BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 46. ROAPAC BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. ROAPAC BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 49. BRAZIL BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. BRAZIL BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 52. MEXICO BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. MEXICO BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 55. ROLA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. ROLA BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 58. ROW BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 59. ROW BLOOD GLUCOSE MONITORING SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)List of Figures
FIG 1. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, PEST ANALYSIS
FIG 8. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA BLOOD GLUCOSE MONITORING SYSTEMS MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE BLOOD GLUCOSE MONITORING SYSTEMS MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC BLOOD GLUCOSE MONITORING SYSTEMS MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA BLOOD GLUCOSE MONITORING SYSTEMS MARKET 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
F. Hoffman-La Roche Ltd.
Abbott Laboratories
Ascencia Diabetes Care Holdings AG
Dexcom Inc.
Medtronic
B. Braun Melsungen AG
Lifescan Inc.
Terumo Medical Corporation
DiamonTech GmbH
Nova Biomedical
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

Publisher :